Parkinson's Disease Tulip


advertisement
Reply
 
Thread Tools Display Modes
Old 02-08-2010, 12:50 PM #1
olsen's Avatar
olsen olsen is offline
Senior Member
 
Join Date: Aug 2006
Posts: 1,860
15 yr Member
olsen olsen is offline
Senior Member
olsen's Avatar
 
Join Date: Aug 2006
Posts: 1,860
15 yr Member
Default Small molecules found to protect cells in multiple models of Parkinson's disease

http://www.eurekalert.org/pub_releas...-smf122409.php

Small molecules found to protect cells in multiple models of Parkinson's disease
FINDINGS: Several structurally similar small molecules appear capable of protecting cells from alpha-synuclein toxicity, a hallmark of Parkinson's disease...
.

Small molecules found to protect cells in multiple models of Parkinson's disease

CAMBRIDGE, Mass. (December 28, 2009) Several structurally similar small molecules appear capable of protecting cells from alpha-synuclein toxicity in multiple models of Parkinson's disease... Misfolded copies of the alpha-synuclein protein in brain cells are a hallmark of Parkinson's disease.


In their article in Disease Models and Mechanisms (DMM), Lindquist scientists report that four related small molecules prevented the development of several cellular traits associated with Parkinson's disease, including the accumulation of alpha-synuclein deposits in the cell, improper protein trafficking from one organelle to another, and damage inflicted on the cells' engines, the mitochondria.

The research is based on a type of brewer's yeast modified to produce too much of the alpha-synuclein protein in its cells. The resulting cells manifest adverse effects similar to those experienced in brain cells from Parkinson's patients...


In all of the models, the compounds improved protein trafficking and decreased mitochondrial damage...

... "There are very deeply rooted processes that connect protein trafficking and mitochondrial viability," says Lindquist... "That emphasizes that the underlying problem caused by alpha-synuclein is a general cellular defect that is part of the machinery of all eukaryotic cells. The specific problems in Parkinson's are due to the neurons being particularly sensitive to that process going awry."...


"Theoretically if a compound is having a beneficial effect on yeast cells, and in a worm, and in primary neurons, then possibly through years and years of work, it might actually be a potential therapeutic avenue or drug," says Tardiff. "Though we started in yeast, one of those compounds could actually have some potential for human health in Parkinson's disease. That's always a lofty goal."


###
The MGH/MIT Morris Udall Center of Excellence in Parkinson Disease Research, the Michael J. Fox Foundation, and the Howard Hughes Medical Institute (HHMI) provided funding for this research.


Full Citation: "Compounds from an unbiased chemical screen reverse both ER-to-Golgi trafficking defects and mitochondrial dysfunction in Parkinson disease models"

Disease Models and Mechanisms, published online December 28, 2009

Linhui Julie Su (1,9,*), Pavan K. Auluck (1,3,*), Tiago Fleming Outeiro (1,10 and Susan Lindquist (1,2), et al
__________________
In the last analysis, we see only what we are ready to see, what we have been taught to see. We eliminate and ignore everything that is not a part of our prejudices.

~ Jean-Martin Charcot


The future is already here it's just not very evenly distributed. William Gibson
olsen is offline   Reply With QuoteReply With Quote
"Thanks for this!" says:
imark3000 (02-08-2010), RLSmi (02-08-2010)

advertisement
Old 02-08-2010, 04:11 PM #2
imark3000 imark3000 is offline
Member
 
Join Date: Nov 2007
Location: Calgary-Canada
Posts: 821
10 yr Member
imark3000 imark3000 is offline
Member
 
Join Date: Nov 2007
Location: Calgary-Canada
Posts: 821
10 yr Member
Default years and years

and years unfortunately they always say that.
Imad
imark3000 is offline   Reply With QuoteReply With Quote
Old 02-08-2010, 04:36 PM #3
olsen's Avatar
olsen olsen is offline
Senior Member
 
Join Date: Aug 2006
Posts: 1,860
15 yr Member
olsen olsen is offline
Senior Member
olsen's Avatar
 
Join Date: Aug 2006
Posts: 1,860
15 yr Member
Default earlier study

(looks to be a good reference site:
http://f1000biology.com/guardpages/e...2526style%253D

earlier published study dealing with alpha Syn, ER stress and ER-Gogli protein trafficking
http://www.sciencemag.org/cgi/content/full/313/5785/324
Science 21 July 2006:
Vol. 313. no. 5785, pp. 324 - 328


-Synuclein Blocks ER-Golgi Traffic and Rab1 Rescues Neuron Loss in Parkinson's Models

Antony A. Cooper,1* Aaron D. Gitler,2* Susan Lindquist2,9| et al
__________________
In the last analysis, we see only what we are ready to see, what we have been taught to see. We eliminate and ignore everything that is not a part of our prejudices.

~ Jean-Martin Charcot


The future is already here it's just not very evenly distributed. William Gibson
olsen is offline   Reply With QuoteReply With Quote
"Thanks for this!" says:
vlhperry (02-08-2010)
Reply

Thread Tools
Display Modes

Posting Rules
You may not post new threads
You may not post replies
You may not post attachments
You may not edit your posts

BB code is On
Smilies are On
[IMG] code is On
HTML code is Off


Similar Threads
Thread Thread Starter Forum Replies Last Post
Gangliosides May Protect Against Parkinson's Disease Stitcher Parkinson's Disease 0 04-27-2009 07:39 AM
Green tea may protect brain cells against Parkinson's ZucchiniFlower Parkinson's Disease 0 12-27-2007 08:17 PM
NSAIDs Protect Against Parkinson's Disease Stitcher Parkinson's Disease 0 11-05-2007 09:26 PM


All times are GMT -5. The time now is 01:05 PM.

Powered by vBulletin • Copyright ©2000 - 2021, Jelsoft Enterprises Ltd.

vBulletin Optimisation provided by vB Optimise v2.7.1 (Lite) - vBulletin Mods & Addons Copyright © 2021 DragonByte Technologies Ltd.
 

NeuroTalk Forums

Helping support those with neurological and related conditions.

 

The material on this site is for informational purposes only,
and is not a substitute for medical advice, diagnosis or treatment
provided by a qualified health care provider.


Always consult your doctor before trying anything you read here.